This wiki has undergone a migration to Confluence found Here
Difference between revisions of "Implementation FAQ:Migration from version 2"
Jump to navigation
Jump to search
Rene spronk (talk | contribs) |
Rene spronk (talk | contribs) |
||
| Line 6: | Line 6: | ||
===Selling point for V3=== | ===Selling point for V3=== | ||
| − | Question: What is the real value of the reference model in V3 – what is the life of the system –this can be a long time for strategic programs. These need to be future-proofed. | + | '''Question:''' What is the real value of the reference model in V3 – what is the life of the system –this can be a long time for strategic programs. These need to be future-proofed. |
| + | *Two documents from the Marketing Committee's document page that discuss the rationale for using HL7 version 3: | ||
| + | **[http://www.hl7.org/Library/Committees/marketing/20041210%5Fv3%5Fvalue%5Fproposition%2Edoc Draft HL7 v3 Value Proposition Document] | ||
| + | **[http://www.hl7.org/Library/Committees/marketing/Canada%5FInfosheet%2Ezip Canada Infoway v3 Infosheet] | ||
| − | + | '''Question:''' I have a running system using V2, how do I justify moving to V3, especially as V2 just keeps getting better. | |
| − | * | + | *The justification of v3 lies in those areas that v2 doesn't cover (e.g. inter-organizational communications, CDA, clinical genomics). |
| − | |||
Revision as of 11:08, 26 May 2006
This page contains questions related to the migration of HL7 version 2 to version 3, mostly from a non-technical perspective.
Back to Implementation FAQ
Questions
Selling point for V3
Question: What is the real value of the reference model in V3 – what is the life of the system –this can be a long time for strategic programs. These need to be future-proofed.
- Two documents from the Marketing Committee's document page that discuss the rationale for using HL7 version 3:
Question: I have a running system using V2, how do I justify moving to V3, especially as V2 just keeps getting better.
- The justification of v3 lies in those areas that v2 doesn't cover (e.g. inter-organizational communications, CDA, clinical genomics).
